Form 8-K - Current report:
SEC Accession No. 0001628280-19-011974
Filing Date
2019-09-27
Accepted
2019-09-27 17:16:59
Documents
3
Period of Report
2019-09-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kifetrobanfdagrant.htm 8-K 38491
2 EXHIBIT 99.1 pressreleaseexhibitfdagrant.htm EX-99.1 27156
3 cumberlandlogoa03.jpg GRAPHIC 55567
  Complete submission text file 0001628280-19-011974.txt   143268
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191122979
SIC: 2834 Pharmaceutical Preparations